<?xml version="1.0" encoding="UTF-8"?>
<p>In a prospective randomised placebo-controlled double blind trial - CITRIS-ALI - ascorbate 50 mg/kg or placebo was given q 6 h intravenously for 96 h to 167 patients with sepsis and ARDS; no significant difference was seen at 96 h in organ dysfunction scores (SOFA), inflammation marker CRP or thrombomodulin (for vascular integrity) (
 <xref rid="b167-ijmm-46-02-0489" ref-type="bibr">167</xref>). However, patients treated with vitamin C had a significant benefit in 28-day mortality, transfer from ICU by hour 168, number of ICU-free days by day 28, and number of hospital-free days.
</p>
